## generative adversarial networks and variational autoencoders) to

develop synthetic defect-image data. According to Nitin Kaul, the

associate director of IT architecture, the gen-AI-enhanced system has

helped Merck “understand root causes of rejects, optimize processes,

and reduce overall false rejects across various product lines by more

than 50%.”

Drug discovery is also being transformed by gen AI. Absci, a drug-

development company, is now able to create and validate therapeutic de